Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Chrysin Limits Dry Eye via Ferroptosis and Inflammation
2026-09-23
A 2026 study links NOX2-driven oxidative stress and STING/NLRP3 inflammatory signaling to corneal epithelial injury in dry eye, and reports that chrysin suppresses both pathways in experimental models. The findings provide mechanistic support for chrysin as a preclinical research candidate while leaving clinical efficacy, dosing, and pathway specificity to be established.
-
Rimonabant as a Receptor-Resolution Tool
2026-09-23
Rimonabant (SR141716) provides a rigorous way to test whether cannabinoid-related phenotypes depend on CB1 signaling. This article connects CB1 pharmacology with terpene analgesia research and translates receptor attribution into practical assay decisions.
-
Praeruptorin A Experimental Workflows
2026-09-22
Build reproducible Praeruptorin A studies around orthogonal readouts for inflammation, ferroptosis, cardiomyopathy research, and metastatic behavior. This workflow-focused guide connects concentration design, pathway validation, and troubleshooting to practical bench decisions.
-
From Hypoxia to Viability: Smarter GBM Models
2026-09-22
High-cell-density glioblastoma models can reproduce hypoxia-linked therapy resistance, but translational confidence depends on measuring both mechanism and cell-state outcomes. This thought-leadership guide explains how Calcein-AM Propidium Iodide staining can add a practical viability layer to engineered tumor models without confusing membrane integrity with complete biological function.
-
Cy3 TSA Fluorescence System Kit for Spatial Assays
2026-09-21
The Cy3 TSA Fluorescence System Kit strengthens IHC, ICC, and HRP-compatible ISH when conventional fluorescence is too dim to resolve rare targets. This guide translates proximity-proteomics findings into practical staining workflows, controls, optimization experiments, and spatial validation strategies.
-
H 89 2HCl: PKA Control in Neuronal Calcium Signaling
2026-09-21
H 89 2HCl is more than a routine PKA inhibitor: used with cAMP, phosphorylation, membrane-trafficking, and calcium readouts, it can help translational researchers test how kinase activity connects glucocorticoid signaling to Kv2.1 and CaV1.2 regulation.
-
Partial BACE1 Inhibition and Synaptic Function
2026-09-20
Satir et al. tested whether moderate β-secretase inhibition could lower amyloid-β secretion without disrupting neuronal communication. In primary rat cortical cultures, reductions below 50% preserved synaptic transmission, whereas stronger inhibition reduced both amyloid-β release and synaptic activity, supporting exposure-sensitive strategies for Alzheimer’s disease research.
-
One-step TUNEL Cy5 Apoptosis Detection Kit
2026-09-19
Learn how SKU K1135 supports interpretable DNA-fragmentation measurements across cultured cells and tissue sections. This scenario-based guide covers assay selection, protocol controls, spectral settings, interpretation, and practical vendor evaluation for apoptosis research.
-
GDC-0941: Reliable PI3K/Akt Assays
2026-09-18
Learn how GDC-0941 (SKU A8210) can improve interpretation of cell viability, proliferation, pathway, and apoptosis assays through controlled PI3K/Akt inhibition. This scenario-based guide covers dosing, solvent handling, endpoint selection, data interpretation, and practical supplier evaluation.
-
PD 0332991: Practical CDK4/6 Assay Workflows
2026-09-18
Build more informative cancer assays with PD 0332991 by separating reversible growth arrest from true cell killing. This workflow combines Rb-pathway validation, time-resolved cell-cycle analysis, and orthogonal viability measurements for stronger breast cancer and tumor-response studies.
-
GSTA1, Glutathione Loss, and α-Amanitin Hepatotoxicity
2026-09-17
A 2026 study identifies GSTA1 as an unexpected driver of α-amanitin liver injury rather than solely a protective detoxification enzyme. By combining multi-omics, protein-interaction assays, animal pathology, and genetic perturbation, the work links NRF2-associated GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and hepatocyte damage.
-
Crystal Violet Staining Solution for Biofilm Assays
2026-09-17
Use Crystal Violet Staining Solution to convert attached-cell and colony phenotypes into high-contrast, imageable data across proliferation, migration, invasion, and biofilm workflows. This guide connects a practical nuclear staining dye workflow with the clade-resolved biofilm findings reported for Candidozyma auris, while clearly separating biomass measurement from viability and antimicrobial susceptibility.
-
Cell Integrity and Ploidy Limits in Budding Yeast
2026-09-16
Barker, Murray, and Bell used budding yeast to define how far whole-genome duplication can proceed before cell physiology fails. Their study found a maximum DNA content of 32–64C and linked this boundary to cell-surface stress, while also identifying repression of ergosterol-biosynthesis genes as a transcriptional response to increased ploidy; these findings are detailed in the reference study.
-
Reparixin for CXCR1/2 Signaling Workflows
2026-09-16
Reparixin is a practical CXCR1/2 inhibitor for separating CXCL8 receptor signaling from upstream inflammatory triggers. This guide adapts it for neutrophil chemotaxis, tissue-injury models, and mechanistic follow-up of MRSA extracellular-vesicle effects in oral cancer research.
-
How Near-Death Cells Acquire Metastatic States
2026-09-15
The Cell Reports study by Conod, Silvano, and Ruiz i Altaba proposes that impending cell death can actively generate stable prometastatic tumor states rather than merely select pre-existing aggressive cells. Its findings connect ER stress, PERK–CHOP signaling, GLI and NANOG-dependent reprogramming, and cytokine-mediated communication to the formation of PAMEs and PIMs, offering a framework for studying metastasis after cytotoxic stress.